Skip to content
OpenCapital
Get started

Baxter International BAX Medication Delivery — Net Sales

Discontinued — last reported Q2 '23

Other product segments

Infusion Therapies & Technologies
$981M-1.3%
Care & Connectivity Solutions
$435M+1.9%
Drug Compounding
$320M+30.1%
Advanced Surgery
$304M+13.4%
Injectables & Anesthesia
$301M-10.1%
Front Line Care
$270M-2.5%

Similar metrics at other companies

Insulet logo
PODDDrug Delivery — Total Revenue
$3.3M-77.9%
West Pharmaceutical Services logo
WSTDelivery Systems — Revenue
$144.9M+20.8%
Neurocrine Biosciences logo
NBIXNet product sales — Total revenues
$811M+43.9%
Nordson logo
NDSNMedical and Fluid Solutions — Revenue
$219.47M+31.6%
ResMed logo
RMDDevices — Net revenue by segment
$1.47B+8.8%
Crane Co. logo
CRPayment Acceptance and Dispensing Products — Net Sales
$223.8M+6.1%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Baxter International’s 10-Q, filed July 27, 2023, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's medication delivery — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's medication delivery — net sales?
Baxter International (BAX) reported medication delivery — net sales of $761M in Q2 2023.
How has Baxter International's medication delivery — net sales changed year-over-year?
Baxter International's medication delivery — net sales increased by 7.2% year-over-year, from $710M to $761M.
What does medication delivery — net sales mean?
The total net revenue earned from the company's medication delivery product line.
How do you interpret medication delivery — net sales?
An increase suggests strong market adoption and effective pricing strategies for infusion and delivery equipment, while a decrease may indicate competitive pressure or reduced hospital capital expenditure.
How does medication delivery — net sales compare across companies?
Comparable to revenue segments for medical device peers focused on hospital consumables and infusion therapy systems.